Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:25:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1; this is a minor site maintenance update that does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:30:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding/status notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:54:14.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor UI and metadata updates include a glossary toggle, label capitalization tweaks (Last Update Submitted that Met QC Criteria and No FEAR Act data), and a new revision indicator (v3.4.0), which do not alter study data or core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:29:10.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.3 to v3.3.4. There are no changes to the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:44:44.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new site revision label 'Revision: v3.3.3' appears and the 'HHS Vulnerability Disclosure' link is removed; these are minor UI/site maintenance changes rather than study content updates.
    Difference
    0.1%
    Check dated 2025-12-23T20:22:50.000Z thumbnail image

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.